Fibroblast Growth Factor-21 Regulates PPARγ Activity and the Antidiabetic Actions of Thiazolidinediones

Dutchak, Paul A., Katafuchi, Takeshi, Bookout, Angie L., Choi, Jang Hyun, Yu, Ruth T., Mangelsdorf, David J., Kliewer, Steven A.·2012·Cell
DOI 10.1016/j.cell.2011.11.062

Cited by (538)

Items 401–500 of 538

  1. The endocrine FGFs axis: A systemic anti-fibrotic response that could prevent pulmonary fibrogenesis?
    Mada Ghanem, Gabrielle Archer, Bruno Crestani, Arnaud Mailleux · 2024 · Pharmacology & Therapeutics
  2. FGF-21, a newcomer in the field of hypertension research
    K Eto · 2013 · Journal of Human Hypertension
  3. Beyond obesity – thermogenic adipocytes and cardiometabolic health
    Peter Aldiss, Neele S. Dellschaft, Harold S. Sacks, Helen Budge, Michael Edward Symonds · 2017 · Hormone Molecular Biology and Clinical Investigation
  4. FGF21 serum levels are related to insulin resistance, metabolic changes and obesity in Mexican people living with HIV (PLWH)
    Arguiñe Ivonne Urraza Robledo, Marta Giralt, Faviel F. González-Galarza, Francesc Villarroya, Alberto Alejandro Miranda Pérez, Pablo Ruíz-Flores, María Elena Gutiérrez Pérez, Peré Domingo, Francisco Carlos López-Márquez · 2021 · PLoS ONE
  5. Circulating fibroblast growth factor 21 as a potential biomarker for missed abortion in humans
    Yongkang Yang, Jiaming Wu, Xia Wang, Jianyu Yao, Kim Shijian Lao, Yumei Qiao, Ying Xu, Yue Hu, Yan-hong Feng, Yan Chao Cui et al. · 2021 · Fertility and Sterility
  6. Hepatic Fgf21 Expression Is Repressed after Simvastatin Treatment in Mice
    Panos G. Ziros, Zoi Zagoriti, George Lagoumintzis, Venetsana E. Kyriazopoulou, Ralitsa P. Iskrenova, Evagelia E Habeos, Gerasimos P. Sykiotis, Dionysios V. Chartoumpekis, Ioannis G. Habeos · 2016 · PLoS ONE
  7. Sex Dimorphism in the Fgf21 Gene Expression in Liver and Adipose Tissues is Dependent on the Metabolic Condition
    Н. М. Бажан, Tatiana Jakovleva, Natalia Balybina, Anastasia Dubinina, E. I. Denisova, Natalia A. Feofanova, Makarova En · 2019 · OnLine Journal of Biological Sciences
  8. Rac-Dependent Signaling from Keratinocytes Promotes Differentiation of Intradermal White Adipocytes
    Takehiko Ueyama, Megumi Sakuma, Mio Nakatsuji, Tatsuya Uebi, Takeshi Hamada, Atsu Aiba, Naoaki Saito · 2019 · Journal of Investigative Dermatology
  9. PPARα agonist WY-14,643 induces adipose atrophy and fails to blunt chronic ethanol-induced hepatic fat accumulation in mice lacking adipose FGFR1
    Yunhui Xu, Krista L. Denning, Yongke Lu · 2021 · Biochemical Pharmacology
  10. Naturally improving insulin resistance with amorfrutins
    Philippe Lefèbvre, Bart Staels · 2012 · Proceedings of the National Academy of Sciences
  11. The role of FGF21 in the interplay between obesity and non-alcoholic fatty liver disease: a narrative review
    Cristina Elena Negroiu, Iulia Tudorașcu, Maria Cristina Beznă, Adrian Ungureanu, Sorina Octavia Honţaru, Suzana Dănoiu · 2024 · Romanian Journal of Morphology and Embryology
  12. Co-exposure to F-53B and nanoplastics induced hepatic glucolipid metabolism disorders by the PI3K-AKT signaling pathway
    Zhihan Zhang, Mengxing Cui, Han Wang, Wenke Yuan, Ziqi Liu, Huan Gao, Xinchao Guan, Xiaoyu Chen, Lijie Xie, Yu He et al. · 2025 · Environmental Pollution
  13. Combination of Exercise and Intake of Amino Acid Mixture Synergistically Induces Beige Adipocyte Formation in Mice
    Takuya KOJIMA, Nana Esaki, Takanori Tsuda · 2021 · Journal of Nutritional Science and Vitaminology
  14. FGF21 contributes to metabolic improvements elicited by combination therapy with exenatide and pioglitazone in patients with type 2 diabetes
    Ricardo J. Samms, Christine Cheng, Marcel J. Fourcaudot, Sami Heikkinen, Ahmed Khattab, John M. Adams, Eugênio Cersósimo, Curtis L. Triplitt, CURTISS L. PUCKETT, Kostas Tsintzas et al. · 2022 · American Journal of Physiology-Endocrinology and Metabolism
  15. Tgr5 −/− mice are protected from ethanol-induced metabolic alterations through enhanced leptin and Fgf21 signaling
    Sabita Pokhrel, Matthew Dilts, Zachary Stahl, Shannon Boehme, Gabrielle Frame, John Y.L. Chiang, Jessica M. Ferrell · 2023 · Hepatology Communications
  16. PPARγ
    Frederick W. Quelle, Curt D. Sigmund · 2013 · Circulation Research
  17. Practical prospects for boosting hepatic production of the “pro-longevity” hormone FGF21
    Mark Frederick McCarty · 2015 · Hormone Molecular Biology and Clinical Investigation
  18. Genetics and Clinical Characteristics of PPARγ Variant-Induced Diabetes in a Chinese Han Population
    Siqian Gong, Xueyao Han, Meng Li, Xiaoling Cai, Wei Liu, Yingying Luo, Si-min Zhang, Lingli Zhou, Yumin Ma, Xiuting Huang et al. · 2021 · Frontiers in Endocrinology
  19. A zebrafish pparγ gene deletion reveals a protein kinase network associated with defective lipid metabolism
    Yan Zhao, L. Filipe C. Castro, Óscar Monroig, Xiaojuan Cao, Yonghua Sun, Jian Gao · 2022 · Functional & Integrative Genomics
  20. Fibroblast growth factor 21 resistance is associated with body shape in patients with type 2 diabetes complicating hypertension
    Jing Gan, Zikun Duan, Lu Tang, Zhen Liu, Huiying Tian, Maolan Wu, Yanxue Bi, Xingchao Pan, Wenjun Wang, Xiaotang Gao et al. · 2023 · Frontiers in Cardiovascular Medicine
  21. Research progress on the role of FGF21 in insulin resistance
    Haixin Zhang, Rongyu Zhu, Quanhao Sun, Likun Du · 2025 · Frontiers in Endocrinology
  22. Adipose angiotensin II type 1 receptor-associated protein ameliorates metabolic disorders via promoting adipose tissue adipogenesis and browning
    Chengting Luo, Na Lv, Zai Chang, Qiannuo Qu, Jianzhen Huang · 2017 · European Journal of Cell Biology
  23. Heparin is essential for optimal cell signaling by FGF21 and for regulation of βKlotho cellular stability
    Seong J. An, Jyotidarsini Mohanty, Francisco Tomé, Yoshihisa Suzuki, Irit Lax, Joseph Schlessinger · 2023 · Proceedings of the National Academy of Sciences
  24. Response of fibroblast growth factor 21 to meal intake and insulin infusion in patients on maintenance haemodialysis
    Mark Reinhard, Jan Frystyk, Bente Jespersen, Else Randers, Bo Martin Bibby, Per Ivarsen · 2015 · Clinical Endocrinology
  25. Fibroblast Growth Factor 21 Mimetics for Treating Atherosclerosis
    Kelvin H. M. Kwok, Karen S.L. Lam · 2017 · Endocrinology and Metabolism
  26. Molecular characterization of peroxisome proliferator activated receptor gamma (PPARγ) in loach Misgurnus anguillicaudatus and its potential roles in fatty acid metabolism in vitro
    Yun Cui, Xiao Liang, Xiaojuan Cao, Jian Gao · 2018 · Process Biochemistry
  27. FGF21-protection against fructose-induced lipid accretion and oxidative stress is influenced by maternal nutrition in male progeny
    Elena Fauste, Silvia Rodrigo, Lourdes Rodríguez, Cristina Donis, Antonia Garcı́a, Coral Barbas, Juan J. Álvarez‐Millán, Maria Isabel Panadero, Paola Otero, Carlos Bocos · 2019 · Journal of Functional Foods
  28. Exercise promotes cardiac-specific fibroblast growth factor 21 expression
    Yuan Guo, Qiong Liu, Yajun Gui, Cai-xiu Liao, Danyan Xu · 2015 · International Journal of Cardiology
  29. FGF21 and APOA1 mRNA-based therapies for the treatment of experimental acute pancreatitis
    Amaya López-Pascual, Eva Santamaría, Nuria Ardaiz, Iker Uriarte, Tiffany Palmer, Anne-Renee Graham, Celia Gomar, Roberto C. Barbero, Maria Ujue Latasa, María Arechederra et al. · 2025 · Journal of Translational Medicine
  30. Prepregnancy GLP ‐ 1RA use improves maternal lipid metabolism via liver‐secreted FGF21 during pregnancy in HFD ‐fed dams
    Haonan Guo, Yingyu Jing, Yifan Zhang, Lin Song, Wenjing Wu, Jingyue Wang, Mengjun Wang, Xinyi Niu, Mingxi Wang, Xingyan Pan et al. · 2025 · Obesity
  31. Sex Differences in Ketogenic Diet Response Reveal Gonadal Hormone Interaction With FGF21 in Mice
    Yuan Zhang, Jesse D. Cochran, Rhonda Souvenir, Warren C. Tai, Ruiyou Xia, Brendan S Gladwin, Natalie B Barton, Renata Oliveira Pereira, E. Dale Abel · 2025 · Journal of the Endocrine Society
  32. Novel target to enhance radioiodine uptake in thyroid cancer
    Gregory A. Brent, Takahiko Kogai · 2013 · Nature Reviews Endocrinology
  33. Serum Levels of Fibroblast Growth Factor 21 in Type 2 Diabetic Patient
    Yunes Panahi · 2016 · Acta Endocrinologica (Bucharest)
  34. 4-Phenylbutyric acid improves free fatty acid-induced hepatic insulin resistance in vivo
    Sandra Pereira, Jessy Moore, Jia-Xu Li, Wen Yu, Husam Ghanim, Filip Vlavcheski, Yemisi Deborah Joseph, Paresh Dandona, Allen Volchuk, Carolyn L. Cummins et al. · 2021 · Endocrine Connections
  35. Studying sex differences in responses to fibroblast growth factor 21 administration in obese mice consuming a sweet-fat diet
    Н. М. Бажан, Tatiana Jakovleva, A. Yu. Kazantseva, Н. Е. Костина, P. E. Orlov, Natalia Balybina, Konstantin O. Baranov, Makarova En · 2023 · Vavilov Journal of Genetics and Breeding
  36. Fibroblast Growth Factor 21 Deficiency Attenuates Experimental Colitis-Induced Adipose Tissue Lipolysis
    Liming Liu, Cuiqing Zhao, Ying Yang, Xiaoxia Kong, Tuo Shao, Li Ren, Xinyu Zhuang, Baishuang Yin, Gerald Wayne Dryden, Craig James McClain et al. · 2017 · Gastroenterology Research and Practice
  37. RIFL aims to be a new player in lipid metabolism
    Jacqueline M. Stephens · 2012 · American Journal of Physiology-Endocrinology and Metabolism
  38. Functions of FGF21 and its role in cardiac hypertrophy
    Lei Chen, Meng Gao, Sang‐Bing Ong, Guohua Gong · 2025 · Journal of Advanced Research
  39. FGF2 Mediated USP42‐PPARγ Axis Activation Ameliorates Liver Oxidative Damage and Promotes Regeneration
    Nanfei Yang, Qiang Tian, Zhenli Lei, Shuxin Wang, Nan Cheng, Zhen Wang, Xianqin Jiang, Xuqun Zheng, Wenjing Xu, M. Ye et al. · 2025 · Advanced Science
  40. AMP activated kinase negatively regulates hepatic Fetuin-A via p38 MAPK-C/EBPβ/E3 Ubiquitin Ligase Signaling pathway
    Vishal M Kothari, Jeganathan Ramesh Babu, Suresh T. Mathews · 2022 · PLoS ONE
  41. Patterns of Circulating Fibroblast Growth Factor 21 in Subjects with and without Type 2 Diabetes
    Jingyi Lu, Haoyong Yu, Yifei Mo, Xiaojing Ma, Yaping Hao, Wei Lu, Huating Li, Yuqian Bao, Jian Zhou, Weiping Jia · 2015 · PLoS ONE
  42. Research Progress of Fibroblast Growth Factor 21 in Fibrotic Diseases
    Min-Qi Jia, Cha‐Xiang Guan, Jia‐Hao Tao, Yong Zhou · 2022 · Oxidative Medicine and Cellular Longevity
  43. The emerging role of fibroblast growth factor 21 in diabetic nephropathy
    Song Mao, Xianguo Ren, Jianhua Zhang · 2016 · Journal of Receptors and Signal Transduction
  44. α1-Adrenergic receptor downregulates hepatic FGF21 production and circulating FGF21 levels in mice
    Katsunori Nonogaki, Takao Kaji · 2016 · Neuroscience Letters
  45. Rapamycin‐ameliorated diabetic symptoms involved in increasing adiponectin expression in diabetic mice on a high‐fat diet
    Fanghua Gong, Yanna Ye, Jinmeng Li, Haiyang Zhao, Xiaokun Li · 2017 · The Kaohsiung Journal of Medical Sciences
  46. PPAR Modulation Through Posttranslational Modification Control
    Natália Bernardi Videira, Marieli M. G. Dias, Maiara Ferreira Terra, Vinícius M. de Oliveira, Marta García‐Arévalo, Thayná Mendonça Avelino, Felipe Rafael Torres, Fernanda Aparecida Heleno Batista, Ana Carolina Migliorini Figueira · 2021 · Springer eBooks
  47. Modulating the Genomic Programming of Adipocytes
    Anne Loft, Søren Fisker Schmidt, Susanne Mandrup · 2015 · Cold Spring Harbor Symposia on Quantitative Biology
  48. The SUMO Family: Mechanisms and Implications in Thyroid Cancer Pathogenesis and Therapy
    Bahejuan Jiaerken, Wei Liu, Jiaojiao Zheng, Wei‐Feng Qu, Qiao Yun Wu, Zhilong Ai · 2024 · Biomedicines
  49. FGF1 as a New Promising Therapeutic Target in Type 2 Diabetes: Advances in Research and Clinical Trials
    Tian-Sheng Bu, Xiaojuan Gao, Rui-Na Zhang, Ying Xu · 2025 · Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy
  50. Alcoholic fatty liver is blunted by rFGF21 administration in mice lacking adipose FGFR1: The role of FGF21 in PPARα-mediated regulation of adipose tissue mass
    Yunhui Xu, Yongke Lu · 2022 · Biochemical and Biophysical Research Communications
  51. Association of Elevated Plasma FGF21 and Activated FGF21 Signaling in Visceral White Adipose Tissue and Improved Insulin Sensitivity in Gestational Diabetes Mellitus Subtype: A Case-Control Study
    Ning Wang, Bo Sun, Haonan Guo, Yingyu Jing, Ruan Qi, Mengjun Wang, Yang Mi, Huan Chen, Lin Song, Wei Cui · 2021 · Frontiers in Endocrinology
  52. TCF4/β‑catenin complex is directly upstream of FGF21 in mouse stomach cancer cells
    Jihua Pei, Na Song, Limin Wu, Jinbo Qi, Shenglong Xia, Changlong Xu, Bo Zheng, Jun Yang, Yanyan Qiu, Haijun Wang et al. · 2017 · Experimental and Therapeutic Medicine
  53. Adipocyte FGF21 Signaling Defect Aggravated Adipose Tissue Inflammation in Gestational Diabetes Mellitus
    Lun Hua, Yi Yang, Haoqi Zhang, Xuemei Jiang, Chao Jin, Bin Feng, Lianqiang Che, Shengyu Xu, Yan Lin, De Wu et al. · 2024 · Nutrients
  54. Female rats have a different healing phenotype than males after anterior cruciate ligament rupture with no intervention
    Jodie L. Morris, Hayley L. Letson, Erik Biroš, Peter J.C. McEwen, Geoffrey Phillip Dobson · 2022 · Frontiers in Medicine
  55. Lipid Peroxidation as a Link between Unhealthy Diets and the Metabolic Syndrome
    Arnold Nola Onyango · 2021 · IntechOpen eBooks
  56. FOXO1 represses PPARα-Mediated induction of FGF21 gene expression
    Ana Luísa De Sousa‐Coelho, Mar Gacias, Brian Timothy O'Neill, Joana Relat, Wolfgang Link, Diego Haro, Pedro F. Marrero · 2023 · Biochemical and Biophysical Research Communications
  57. Glibenclamide promotes FGF21 secretion in interscapular BAT and attenuates depression-like behaviors in male mice with HFD-induced obesity
    Yi‐Ying Kuo, Hao-Yeh Tsai, Yu‐Min Kuo, Shun‐Fen Tzeng, Po-See Chen, Po‐Hung Hsu, Ya‐Tin Lin, Pei‐Chun Chen · 2023 · Life Sciences
  58. [Study on relationship between human ABO blood groups and type A behavior pattern].
    X Mao, M Xu, Simon Mu, Y Ma, Ming‐Liang He · 1991 · PubMed
  59. FGF21 drives a shift in adipokine tone to restore metabolic health
    Andrew Charles Adams, Alexei Kharitonenkov · 2013 · Aging
  60. Maternal obesity impairs fetal brown adipogenesis by attenuating fetal FGF21 signaling
    Lun Hua, Wen Shen, Dengfeng Gao, Yi Yang, Xiaohan Yang, Haoqi Zhang, Siyuan Liu, Luting Liu, Yaxue Cao, Xuemei Jiang et al. · 2025 · Cell Reports
  61. Fenofibrate ameliorates olanzapine’s side effects without altering its central effect: emphasis on FGF-21–adiponectin axis
    Aya Galal, Wesam M. El-Bakly, Sara S. El-Kilany, Azza A. Ali, Ebtehal El-Demerdash · 2021 · Behavioural Pharmacology
  62. An fgf21-like gene from swamp eel (Monopterus albus): Recombinant expression and its potential roles in glucose and lipid homeostasis
    Shuting Zheng, Jianfen Wu, Shenghan Xiang, Yuwei Zang, Dan Kong, Xiping Wei, Wenxiu Sun, Wei Li · 2022 · Comparative Biochemistry and Physiology Part A Molecular & Integrative Physiology
  63. A Tryptophan Hydroxylase Inhibitor Decreases Hepatic FGF21 Expression and Circulating FGF21 in Mice Fed A High-Fat Diet
    Katsunori Nonogaki, Takao Kaji, Mari Murakami · 2018 · Neuropsychiatry
  64. Muscle cells affect the promoting effect of FGF21 on lipid accumulation in porcine adipocytes through AhR/FGFR1 signaling pathway
    Shengda Qiu, Xiaolei Ding, Xiangfei Ma, Lifan Zhang, Jie Chen, Wei Wei · 2025 · Biochemical and Biophysical Research Communications
  65. The adiponectin agonist AdipoRon accelerates osteoporosis development in two different models and modulates adipocyte differentiation
    Julia Halper, Sarah Nicolas, Federica Gilardi, Carine Winkler, Maria Materozzi, Mariano Schiffrin, Jean‐Yves Jouzeau, Claudine Blin‐Wakkach, Béatrice Desvergne, Joëlle Chabry et al. · 2025 · Bone
  66. Cladosporols and PPARγ: Same Gun, Same Bullet, More Targets
    Roberta Rapuano, Antonella Mercuri, Sabrina Dallavalle, Salvatore Moricca, Antonio Lavecchia, Angelo Lupo · 2024 · Biomolecules
  67. The PPAR System in Diabetes
    Jean-Claude Ansquer, Christelle Foucher · 2013 · Contemporary diabetes
  68. A Tryptophan Hydroxylase Inhibitor Increases Hepatic FGF21 Production and Decreases Hepatic Gluconeogenesis Independently of Insulin in db/db Mice
    Katsunori Nonogaki, Takao Kaji, Mari Murakami · 2018 · Neuropsychiatry
  69. Fibroblast Growth Factor 21 is a Regulator of Energy Metabolism in the Liver and Adipose Tissue
    Niina Matikainen · 2014 · Elsevier eBooks
  70. Bone and Energy Metabolism
    Clifford james Rosen · 2017 · Molecular and integrative toxicology
  71. Transcriptomic and metabolomic insights into the enantioselective effects of chiral fungicide penflufen and its enantiomers on multi-endpoints in the liver for mice
    Shanshan Di, Zhiwei Bao, Huiyu Zhao, Zhenzhen Liu, Peipei Qi, Zhiwei Wang, Yuanxiang Jin, Xinquan Wang · 2025 · Journal of Hazardous Materials
  72. Pregnancy-to-lactation transition remodels mammary adipocytes via p38 MAPK-dependent adipogenesis
    Tao Luo, Nannan Jiang, Chaoqun Wu, Wenying Zhang, Jianxin Liu, Juan J. Loor, Hengbo Shi · 2025 · Journal of Dairy Science
  73. Fibroblast Growth Factor 21 as a Regulator of Energy Metabolism in the Liver and Adipose Tissue
    Niina Matikainen, Sanni Söderlund · 2019 · Elsevier eBooks
  74. Impaired Fibroblast Growth Factor 21 (FGF21) Associated with Visceral Adiposity Leads to Insulin Resistance: The Core Defect in Diabetes Mellitus
    Unnati Jain, Priyanka Srivastava, Ashwani Sharma, Subrata Sinha, Surabhi Johari · 2024 · Current Diabetes Reviews
  75. The role of fibroblast growth factors in cell and cancer metabolism
    Jessica Price, Chiara Francavilla · 2025 · FEBS Letters
  76. The impact of LDLR function on fibroblast growth factor 21 levels
    Joost Besseling, Kwok Leung Ong, Roeland Huijgen, Kerry‐Anne Rye, G. Kees Hovingh, Barbara A. Hutten, Gilles C. Lambert · 2015 · Atherosclerosis
  77. Fibroblast growth factor-21 may be a potential novel drug for preventing the development of traumatic TMJ bony ankylosis
    Su-Xia Liang, Ying‐Bin Yan · 2013 · Journal of Medical Hypotheses and Ideas
  78. A Polymorphism in the FGF21 Gene is a Novel Risk Variant for Metabolic-Associated Steatohepatitis
    Asmaa Elsayed · 2020 · The Sydney eScholarship Repository (The University of Sydney)
  79. Endogenous GDF15 and FGF21 additively alleviate hepatic steatosis and insulin resistance in obese mice
    Satish Patel, Afreen Haider, Anna Álvarez-Guaita, Guillaume Bidault, Julia S. El-Sayed Moustafa, Esther Guiu‐Jurado, John A. Tadross, James Warner, James Harrison, Sam Virtue et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  80. Endocrinology and metabolism
    Xiaokun Li · 2024 · Elsevier eBooks
  81. Secretory Malfunction
    Jürgen Eckel · 2018 · Elsevier eBooks
  82. Heightened TPD52 linked to metabolic dysfunction and associated abnormalities in zebrafish.
    Hsin-Hung Lai, K. Jeng, Chung-Tsui Huang, An-Ju Chu, G. Her · 2024 · Archives of Biochemistry and Biophysics
  83. Advancements in understanding the role and mechanisms of mitochondria in diabetes: A comprehensive review
    Xia Ge, Min Ye, Aihua Fei, Qingping Zhang, Aihong Yuan · 2025 · The Journal of Steroid Biochemistry and Molecular Biology
  84. Ubiquitin-like modifications in adipose tissue development and obesity: New insights
    Shayantani Chakraborty, Weiqin Chen · 2026 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  85. Combination Gene Therapy with AAV-Based Vectors Ameliorates the Phenotype of Type 2 Diabetes in Diet-Induced Obese and db/db Mice
    Ramkumar Rajendiran, Subhajit Pathak, Ashish Kumar, Soumita Bhaumik, Sonal Amit, Sai Prasad Pydi, Giridhara Rao Jayandharan · 2026 · Molecular Pharmaceutics
  86. mAb about FGF21
    Chris Cain · 2013 · Science-Business eXchange
  87. The Immune System and Inflammation in Type 2 Diabetes
    Rebeca García Macedo · 2019 · Springer eBooks
  88. Gut microbiota interaction in host lipid metabolism
    Rachel M. Golonka, Ahmed A. Abokor, James Mukasa Ntambi, Matam Vijay–Kumar · 2020 · Elsevier eBooks
  89. Lipid Response to Amino Acid Starvation in Fat Cells: Role of FGF21
    Albert Pérez‐Martí, Pedro F. Marrero, Diego Haro, Joana Relat · 2019 · Springer eBooks
  90. SUMO wars
    ffolliott Martin Fisher, Eleftheria Maratos–Flier · 2013 · Molecular Metabolism
  91. The PPAR System in Diabetes
    Jean-Claude Ansquer · 2023 · Contemporary diabetes
  92. Growth factors reviews
    Xiaokun Li · 2024 · Elsevier eBooks
  93. Die nicht-alkoholische Fettlebererkrankung: Eine Systemerkrankung
    Anna‐Sophia Leven, CD Fingas, Ali E. Canbay · 2017 · Adipositas - Ursachen Folgeerkrankungen Therapie
  94. Pathophysiology and Pharmacology of FGFs
    Xiaokun Li · 2018 · Elsevier eBooks
  95. The Metabolic Effects of FGF21: From Physiology to Pharmacology
    Parkyong Song · 2020 · JoLS Journal of Life Sciences
  96. Regulationsmuster
    Bernhard Kleine, Winfried G. Rossmanith · 2020 · Springer eBooks
  97. Modulation of the adipogenic master regulator PPARγ
    Ismayil Taşdelen · 2014 · Utrecht University Repository (Utrecht University)
  98. FGF2 disruption enhances thermogenesis in brown and beige fat to protect against obesity and hepatic steatosis
    Haifang Li, Xinzhi Zhang, Cheng Zhi Huang, Huan Liu, Shuang Liu, Qiang Zhang, Mei Dong, Mengjie Hou, Yiming Liu, Hai Lin · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  99. FGF21
    Tsz Wai Cheng, Po Sing Leung · 2017 · Springer eBooks
  100. The role of metabolic hormone Fibroblast Growth Factor 21 (FGF21) in mammalian hibernation using transgenic ground squirrels
    Bethany Theresa Nelson · 2012 · University of Minnesota Digital Conservancy (University of Minnesota)